All Stories

A new model uses site characterization data and Bayesian statistics to protect offshore energy infrastructure from submarine landslides.

Developed by biopharmaceutical company Ultragenyx, GTX-102 is the first clinically developed drug targeting the genetic causes of Angelman syndrome rather than symptoms.

A Texas A&M professor offers tips to reclaim your peace of mind when things start to feel out of control.

Faculty members from across the university can provide insights on forecasting, storm impacts, emergency response, coastal resilience, recovery efforts and more.

Experienced student affairs professional returns to Aggieland.

Along with this year’s co-sponsors Nestlé Purina Petcare and Nutramax Laboratories Veterinary Sciences, Texas A&M is partnering with Lindau to support a transformational opportunity for young scientists.

A new platform mimics various blood vessel structures, enabling more accurate models of vascular disease and patient-specific research.

Longevity-centric community allows former students, fans the opportunity to reside in environment promoting longer, healthier lives.

Texas A&M's Jinbo Wang and an international team use SWOT satellite data to uncover powerful submesoscale eddies, reshaping our understanding of ocean-climate dynamics.

A Texas A&M economics expert explains recent moves to halt penny production.